Cargando…
Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross‐sectional study
AIMS: Primary outcome was to evaluate patients' satisfaction after being treated with bulk injection therapy polydimethylsiloxane Urolastic (PDMS‐U) for stress urinary incontinence (SUI). Secondary outcomes were: subjective cure, objective cure, severity of SUI symptoms, complications, reinterv...
Autores principales: | Casteleijn, Fenne M., Kowalik, Claudia R., Berends, Claudia, Blaganje, Mija, Lasić Pecev, Mateja, van der Linden, Ellen, Zwolsman, Sandra E., Roovers, Jan‐Paul W. R., Minnee, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497040/ https://www.ncbi.nlm.nih.gov/pubmed/32526063 http://dx.doi.org/10.1002/nau.24417 |
Ejemplares similares
-
Patients’ perspectives on urethral bulk injection therapy and mid-urethral sling surgery for stress urinary incontinence
por: Casteleijn, Fenne M., et al.
Publicado: (2018) -
Urolastic—A New Bulking Agent for the Treatment of Women with Stress Urinary Incontinence: Outcome of 12 Months Follow Up
por: Zajda, Janusz, et al.
Publicado: (2013) -
Efficacy of surgical revision of mesh complications in prolapse and urinary incontinence surgery
por: Kowalik, Claudia R., et al.
Publicado: (2020) -
Urolastic for the treatment of women with stress urinary incontinence: 24-month follow-up
por: Zajda, Janusz, et al.
Publicado: (2015) -
Association of vitamin D deficiency and pelvic organ prolapse in postmenopausal women: a cross-sectional study
por: Legan, Mateja, et al.
Publicado: (2022)